Conviction invests in Xlue: health world model beats frontier models in blind disease prediction
XiongChenyan · x · 2026-11-19
Conviction announced an investment in Xlue, arguing that today's models are excellent academics—having read every paper—but still can't predict when you'll fall sick or which treatment will work. Xlue treats health as a world-model problem rather than next-token prediction; in a third-party double-blind disease prediction study, its Xlue Health World Model substantially outperformed frontier models including Astra.
More from Research
- Researcher calls METR/Anthropic '2x speedup' RSI analysis statistically dubious — jessi_cata · 2026-11-19
- New Multi Agent Coordination Bench shows agent teams coordinate poorly, win by luck — billyuchenlin · 2026-11-19
- KradleBench pits humans and AI in live multi-agent Minecraft evals — lmoroney · 2026-11-19
- ETH's Anymal robot completes 10km autonomous alpine hike with VLM-guided ROAM system — ChongZzZhang · 2026-11-19
- OpenVax codebase grows from 78K to 565K lines in 15 months — iskander · 2026-11-19
- François Fleuret: decoder transformer's elegance — no trade-off hyperparameters — francoisfleuret · 2026-11-19